Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
Recent advances in neuroimmunology are reframing the problem
PMID: 85 HuWSunLGongYZhouYYangPYeZet al
Related articles Related Qustion Melanotan 1: mechanisms of action, clinical applications and safety Dec 8, 2023 Melanotan 1, a synthetic analogue of -MSH, promotes tanning and potentially treating skin conditions
INFORMATION What is Cagrilintide (5mg)
(PMC) (LDN) an evidence-informed, off-label Naturopathic option LDN is an inexpensive, well-tolerated, off-label medication used by many functional medicine and naturopathic clinicians for autoimmune conditions (notably Crohns disease and multiple sclerosis) because it may modulate immune activity and neuroinflammation
